Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CPTP | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | TM9SF1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | RP11-345F18.1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | HERC2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | CTD-2545M3.6 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | SPEF2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | GABPA | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | ATAD3C | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | FAM131B | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | ADGRA3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |